Tenaya Therapeutics Statistics
Total Valuation
TNYA has a market cap or net worth of $162.77 million. The enterprise value is $86.77 million.
| Market Cap | 162.77M |
| Enterprise Value | 86.77M |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TNYA has 217.00 million shares outstanding. The number of shares has increased by 95.26% in one year.
| Current Share Class | 217.00M |
| Shares Outstanding | 217.00M |
| Shares Change (YoY) | +95.26% |
| Shares Change (QoQ) | +23.90% |
| Owned by Insiders (%) | 0.43% |
| Owned by Institutions (%) | 25.14% |
| Float | 216.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 700.18 |
| Forward PS | 15.75 |
| PB Ratio | 1.48 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 385.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.75, with a Debt / Equity ratio of 0.10.
| Current Ratio | 5.75 |
| Quick Ratio | 5.45 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -73.59% and return on invested capital (ROIC) is -43.17%.
| Return on Equity (ROE) | -73.59% |
| Return on Assets (ROA) | -38.46% |
| Return on Invested Capital (ROIC) | -43.17% |
| Return on Capital Employed (ROCE) | -72.58% |
| Weighted Average Cost of Capital (WACC) | 18.57% |
| Revenue Per Employee | $3,214 |
| Profits Per Employee | -$1.19M |
| Employee Count | 70 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.66% in the last 52 weeks. The beta is 2.82, so TNYA's price volatility has been higher than the market average.
| Beta (5Y) | 2.82 |
| 52-Week Price Change | +23.66% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 1.00 |
| Relative Strength Index (RSI) | 46.66 |
| Average Volume (20 Days) | 3,192,776 |
Short Selling Information
The latest short interest is 29.30 million, so 13.50% of the outstanding shares have been sold short.
| Short Interest | 29.30M |
| Short Previous Month | 28.75M |
| Short % of Shares Out | 13.50% |
| Short % of Float | 13.56% |
| Short Ratio (days to cover) | 5.96 |
Income Statement
In the last 12 months, TNYA had revenue of $225,000 and -$83.01 million in losses. Loss per share was -$0.46.
| Revenue | 225,000 |
| Gross Profit | 225,000 |
| Operating Income | -85.86M |
| Pretax Income | -83.01M |
| Net Income | -83.01M |
| EBITDA | -78.32M |
| EBIT | -85.86M |
| Loss Per Share | -$0.46 |
Balance Sheet
The company has $80.89 million in cash and $10.12 million in debt, with a net cash position of $70.77 million or $0.33 per share.
| Cash & Cash Equivalents | 80.89M |
| Total Debt | 10.12M |
| Net Cash | 70.77M |
| Net Cash Per Share | $0.33 |
| Equity (Book Value) | 106.19M |
| Book Value Per Share | 0.49 |
| Working Capital | 79.78M |
Cash Flow
In the last 12 months, operating cash flow was -$64.39 million and capital expenditures -$246,000, giving a free cash flow of -$64.63 million.
| Operating Cash Flow | -64.39M |
| Capital Expenditures | -246,000 |
| Depreciation & Amortization | 7.54M |
| Net Borrowing | n/a |
| Free Cash Flow | -64.63M |
| FCF Per Share | -$0.30 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -38,159.11% |
| Pretax Margin | -36,891.11% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TNYA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -95.26% |
| Shareholder Yield | -95.26% |
| Earnings Yield | -52.69% |
| FCF Yield | -41.03% |
Analyst Forecast
The average price target for TNYA is $4.00, which is 433.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 433.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TNYA has an Altman Z-Score of -4.53 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.53 |
| Piotroski F-Score | 1 |